THE EFFECT OF NITRIC-OXIDE SYNTHASE INHIBITION ON THE PLASMA FIBRINOLYTIC SYSTEM IN SEPTIC SHOCK IN RATS

被引:22
作者
KORBUT, R [1 ]
WARNER, TD [1 ]
GRYGLEWSKI, RJ [1 ]
VANE, JR [1 ]
机构
[1] JAGIELLONIAN UNIV,COLL MED,DEPT PHARMACOL,PL-31531 KRAKOW,POLAND
关键词
LIPOPOLYSACCHARIDE; FIBRINOLYSIS; DISSEMINATED INTRAVASCULAR COAGULATION (DIC); PLASMINOGEN ACTIVATOR INHIBITOR (PAI); NITRIC OXIDE SYNTHASE INHIBITION;
D O I
10.1111/j.1476-5381.1994.tb13066.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We have investigated the effect of pretreatment of rats with nitric oxide (NO) synthase inhibitor, N-G-nitro-L-arginine methyl ester (L-NAME) on the E. coli lipopolysaccharide (LPS)-induced changes in the plasma frbrinolytic system, platelet count, fibrinogen level, as well as in gross and microscopic pathophysiological changes indicative of disseminated intravascular coagulation (DIC) in rats. 2 E. coli LPS (6 mg kg(-1), i.p.) produced a decrease in the levels of plasma fibrinogen and a drop in the blood platelet count 6h after administration. The decrease in fibrinogen but not the drop in platelet count was reversed by pretreatment with L-NAME (30 mg kg(-1), i.p., 24 h and 15 min before administration of LPS). 3 Pretreatment with L-NAME antagonized the LPS-induced activation of fibrinolysis as measured by changes in the euglobulin clot lysis time (ECLT) and enhanced the LPS-induced rise in the plasma level of plasminogen activator inhibitor (PAI). In animals pretreated with L-NAME there was also a marked reduction in the histological changes indicative of DIC. 4 We propose that L-NAME can act as a protective agent in LPS-induced DIC, and this protection is due to an increased generation of PAI following inhibition of NO synthase.
引用
收藏
页码:289 / 291
页数:3
相关论文
共 14 条
[1]  
BICK RL, 1992, INT J HEMATOL, V55, P1
[2]   PROLONGATION OF FIBRINOLYTIC-ACTIVITY OF TISSUE PLASMINOGEN-ACTIVATOR BY NITROVASODILATORS [J].
KORBUT, R ;
LIDBURY, PS ;
VANE, JR .
LANCET, 1990, 335 (8690) :669-669
[3]   SODIUM-NITROPRUSSIDE MODULATES THE FIBRINOLYTIC SYSTEM IN THE RABBIT [J].
LIDBURY, PS ;
KORBUT, R ;
VANE, JR .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) :527-530
[4]   L-NG-NITRO ARGININE (L-NOARG), A NOVEL, L-ARGININE-REVERSIBLE INHIBITOR OF ENDOTHELIUM-DEPENDENT VASODILATATION INVITRO [J].
MOORE, PK ;
ALSWAYEH, OA ;
CHONG, NWS ;
EVANS, RA ;
GIBSON, A .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (02) :408-412
[5]   INHIBITION OF NITRIC-OXIDE SYNTHESIS IN SEPTIC SHOCK - HOW MUCH IS BENEFICIAL [J].
NAVA, E ;
PALMER, RMJ ;
MONCADA, S .
LANCET, 1991, 338 (8782-3) :1555-1557
[6]  
PARAMO JA, 1988, THROMB HAEMOSTASIS, V59, P451
[7]   EFFECT OF NITRIC-OXIDE SYNTHASE INHIBITORS ON HYPOTENSION IN PATIENTS WITH SEPTIC SHOCK [J].
PETROS, A ;
BENNETT, D ;
VALLANCE, P .
LANCET, 1991, 338 (8782-3) :1557-1558
[8]  
PROCTOR RA, 1986, HDB ENDOTOXIN, V4
[9]  
QUAX PHA, 1990, J BIOL CHEM, V265, P15560
[10]   WIDESPREAD TISSUE DISTRIBUTION, SPECIES DISTRIBUTION AND CHANGES IN ACTIVITY OF CA2+-DEPENDENT AND CA2+-INDEPENDENT NITRIC-OXIDE SYNTHASES [J].
SALTER, M ;
KNOWLES, RG ;
MONCADA, S .
FEBS LETTERS, 1991, 291 (01) :145-149